BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  First Round of Late-Breaking Endovascular Clinical Trial Results Announced at VIVA 18

  VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced the first five of 19 highly anticipated late-breaking clinical trial results on Tuesday morning at VIVA 18, hosted at Wynn Las Vegas.

  November 6, 2018

   · 

  9 min read
• Biotech Beach

  Abzena Announces 20m$ Investment into Expansion of Integrated Biotherapeutics Offering (Biologics Drug Substance and ADC) and Makes Key Executive Appointment

  Significant increase in capacity to 2000 L scale in new GMP facility, addition of extra cell line development capacity and extra chemistry laboratory space. Appointment of Richard Milbank as Chief Financial Officer

  November 6, 2018

   · 

  2 min read
• Biotech Beach

  Regulus Announces Successful Restructuring of Sanofi Collaboration

  Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it has amended and restructured its Collaboration and License Agreement with Sanofi (

  November 6, 2018

   · 

  6 min read
• Business

  Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update

  130 patients treated with Agenus’ PD-1 & CTLA-4; clinical benefit >63% treated

  November 6, 2018

   · 

  6 min read
• Business

  Dicerna to Participate in Upcoming November 2018 Investor Conferences

  Dicerna Pharmaceuticals, Inc. today announced that Douglas M. Fambrough, Ph.D., president and chief executive officer, will participate in three investor conferences in November.

  November 6, 2018

   · 

  2 min read
• Genetown

  KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

  KalVista Pharmaceuticals, Inc. today announced that it will present a corporate overview at the following upcoming investor conferences.

  November 6, 2018

   · 

  2 min read
• Business

  Catalent, Inc. Reports First Quarter Fiscal 2019 Results

  Q1'19 revenue of $551.8 million increased 1% as-reported, or 3% in constant currency, from the prior-year period.

  November 6, 2018

   · 

  28 min read
• Biotech Beach

  Scientist.com and HealthEconomics.Com Launch Online Marketplace for Health Economic & Outcomes Research (HEOR) and Real-World Evidence (RWE)

  Award-winning digital tools connect researchers and data providers to deliver tomorrow’s insights today

  November 6, 2018

   · 

  3 min read
• Survey Reveals Canadians Largely Unaware of Threat of Antimicrobial Resistance

  In acknowledgement of World Antibiotic Awareness Week, Nov. 12-18, a new survey examining Canadians’ understanding of antimicrobial resistance (AMR) reveals that many are unfamiliar with and unconcerned about the threat of drug resistance.1,2

  November 6, 2018

   · 

  4 min read
• Biotech Beach

  MEI Pharma To Present at Stifel 2018 Healthcare Conference

  MEI Pharma, Inc. today announced that Daniel P. Gold, Ph.D. will present a corporate update at the Stifel 2018 Healthcare Conference.

  November 6, 2018

   · 

  3 min read